QR Code

131I-Caerin 1.1 and 131I-Caerin 1.9 for the treatment of non-small-cell lung cancer

ObjectiveTo investigate the effect of the 131I-labeled high-affinity peptides Caerin 1.1 and Caerin 1.9 for the treatment of A549 human NSCLC cells.Methods① 3-[4,5-Dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) and plate clone formation assays were performed to confirm the in vitro ant...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Na Liu, Tiantian He, Zewei Xiao, Juan Du, Keke Zhu, Xiongying Liu, Tongsheng Chen, Wenjuan Liu, Guoying Ni, Xiaosong Liu, Tianfang Wang, Jiangtao Quan, Jinhe Zhang, Peipei Zhang, Jianwei Yuan
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Frontiers Media S.A. 2022-08-01
Rangatū:Frontiers in Oncology
Ngā marau:
high-affinity peptides
non-small-cell lung cancer
A549 cells
131I labeling
Caerin peptide
Urunga tuihono:https://www.frontiersin.org/articles/10.3389/fonc.2022.861206/full
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite